Skip to content
value.today

Codexis, Inc. vs Regenxbio Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Regenxbio Inc. is the larger company by market value: $513 M against $140 M for Codexis, Inc., 3.7 times as much (market caps of Oct 26, 2026 for Codexis, Inc. and Oct 6, 2026 for Regenxbio Inc.).
  • Regenxbio Inc. had more revenue: $170 M against $70 M for Codexis, Inc., both in the year to December 2025.
  • Both made a net loss: $44 M for Codexis, Inc. and $194 M for Regenxbio Inc.
  • Codexis, Inc. keeps more of each dollar of sales: a net margin of -62.5% against -113.8% for Regenxbio Inc.
  • Regenxbio Inc. employs more people: 372 against 261 at Codexis, Inc. Each employee brings in about $269,693 of revenue at Codexis, Inc. and $458,172 at Regenxbio Inc.
  • Regenxbio Inc.'s revenue grew faster in its latest fiscal year: +104.5% against +18.6% for Codexis, Inc.
  • Both are in the distress zone of the Altman Z-score.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

044891331782020202120222023202420252026Codexis, Inc. 15Regenxbio Inc. 35

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B201720182019202020212022202320242025Codexis, Inc. $0BRegenxbio Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureCodexis, Inc.
CDXS · #17,521 in the world
Regenxbio Inc.
RGNX · #12,428 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded2002—
Size
Market cap$140 M$513 M
Revenue$70 M$170 M
Net income$-44 M▲ best$-194 M
Employees261372
Valuation
Price to sales1.6×3.3×
Price to book2.8×5.0×
Free cash flow yield-17.0%▲ best-24.6%
Profitability
Gross margin86.7%—
Operating margin-59.3%▲ best-94.6%
Net margin-62.5%▲ best-113.8%
Return on equity-74.9%▲ best-107.0%
Growth
Revenue growth18.6%104.5%▲ best
Revenue growth, 3 years a year-20.2%14.8%▲ best
Financial strength
Debt to equity0.8×—
Cash
Free cash flow margin-33.9%▲ best-74.1%
Strength scores
Piotroski F-score4 of 9—
Altman Z-score zonedistressdistress
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Codexis, Inc. or Regenxbio Inc.?

Regenxbio Inc. is the larger company by market value: $513 M against $140 M for Codexis, Inc., 3.7 times as much (market caps of Oct 26, 2026 for Codexis, Inc. and Oct 6, 2026 for Regenxbio Inc.).

Which makes more money, Codexis, Inc. or Regenxbio Inc.?

Regenxbio Inc. had more revenue: $170 M against $70 M for Codexis, Inc., both in the year to December 2025. Both made a net loss: $44 M for Codexis, Inc. and $194 M for Regenxbio Inc.

Which is more profitable, Codexis, Inc. or Regenxbio Inc.?

Codexis, Inc. keeps more of each dollar of sales: a net margin of -62.5% against -113.8% for Regenxbio Inc.

Which has more employees, Codexis, Inc. or Regenxbio Inc.?

Regenxbio Inc. employs more people: 372 against 261 at Codexis, Inc. Each employee brings in about $269,693 of revenue at Codexis, Inc. and $458,172 at Regenxbio Inc.

Which is growing faster, Codexis, Inc. or Regenxbio Inc.?

Regenxbio Inc.'s revenue grew faster in its latest fiscal year: +104.5% against +18.6% for Codexis, Inc.

Which is financially stronger, Codexis, Inc. or Regenxbio Inc.?

Both are in the distress zone of the Altman Z-score.

Sources#

Every figure on this page comes from these, with the date shown next to it.